ESTA - エスタブリッシュメント・ラボズ・ホ―ルディングス (Establishment Labs Holdings Inc.) エスタブリッシュメント・ラボズ・ホ―ルディングス

 ESTAのチャート


 ESTAの企業情報

symbol ESTA
会社名 Establishment Labs Holdings Inc (エスタブリッシュメント・ラボズ・ホ―ルディングス)
分野(sector) Health Care   ヘルスケア
産業(industry) Industrial Specialties  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 Establishment Labs Holdings Inc. is a medical technology and aesthetics company that is focused on patient safety and aesthetic outcomes and also in the breast aesthetics and reconstruction market. The Company is engaged in the designing developing manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. Its line of silicone gel-filled breast implants branded as MotivaImplants is the centerpiece of its MotivaImagine medical technology platform. The Company’s MotivaImplants are sold in over 60 countries.   エスタブリッシュメント・ラボズ・ホ―ルディングスはコスタリカの医療機器メ―カ―持株会社。子会社を通じて、美容整形手術、再建整形手術、美容皮膚科治療のための医療機器の設計・製造・販売に従事する。同社は「Motiva Implants」の商標名でシリコン・インプラントを製造、また3D画像のシミュレ―ションシステムも提供する。   Establishment Labs Holdings Inc. is a global medical technology company focused on women's health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform. Motiva Implants® are produced at our two manufacturing sites that are compliant with ISO13485:2016, FDA 21 CFR 820 under the MDSAP program, and are currently commercially available in more than 80 countries through exclusive distributors or the Company's direct salesforce. In March 2018, Establishment Labs received approval for an investigational device exemption (IDE) from the FDA and initiated the Motiva Implant® clinical trial in the United States in April 2018. In addition to Motiva Implants®, Establishment Labs' product and technologies portfolio includes the Divina® 3D Simulation System and other products and services.
本社所在地 Building B15 and 25 Coyol Free Zone Alajuela CRI
代表者氏名
代表者役職名
電話番号
設立年月日 41548
市場名 NASDAQ Small Cap
ipoyear 2018年
従業員数
url www.establishmentlabs.com
nasdaq_url https://www.nasdaq.com/symbol/esta
adr_tso
EBITDA EBITDA(百万ドル) -17.35600
終値(lastsale) 23.58
時価総額(marketcap) 482714197.2
時価総額 時価総額(百万ドル) 485.98960
売上高 売上高(百万ドル) 47.66000
企業価値(EV) 企業価値(EV)(百万ドル) 499.57160
当期純利益 当期純利益(百万ドル) -29.69700
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Establishment Labs Holdings Inc revenues increased 83% to $28.5M. Net loss decreased 30% to $11.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Realized Gain/Loss on Derivative-Hedging increase from $4.2M (expense) to $4.5M (income) Initial public offering expenses decrease from $1.6M (expense) to $0K.

 ESTAのテクニカル分析


 ESTAのニュース

   Establishment Labs to Present at the Jefferies Healthcare Conference  2022/06/06 12:00:00 Business Wire
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Founder and Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, will present at the Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 10:30 am Eastern Time. A live webcast of the presentation will
   Establishment Labs GAAP EPS of -$0.24 beats by $0.13, revenue of $38.45M beats by $3.19M  2022/05/09 20:23:37 Seeking Alpha
Establishment Labs press release (ESTA): Q1 GAAP EPS of -$0.24 beats by $0.13.Revenue of $38.45M (+26.9% Y/Y) beats by $3.19M.2022 revenue guidance of $155 million to $165 million vs
   Establishment Labs Reports Record First Quarter 2022 Financial Results  2022/05/09 20:00:00 Wallstreet:Online
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the first quarter ended March 31, 2022. First Quarter Highlights and Outlook Strong momentum with first quarter worldwide sales of $38.5 million, an increase
   Establishment Labs to Announce First Quarter 2022 Financial Results on May 9  2022/04/28 12:00:00 Business Wire
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended March 31, 2022 after the market closes on Monday, May 9, 2022, and will host a conference call at 4:30 pm ET that day to discuss those results. To participate in the conference call, dial (877) 407-8037 (U.S
   Establishment Labs signs $225M credit facility with Oaktree  2022/04/26 12:48:21 Seeking Alpha
Establishment Labs (ESTA) entered into a $225M term loan financing facility with funds managed by Oaktree Capital which could fund its business to cash flow positive.The facility…
   Establishment Labs Announces Jeffrey Bettinger Has Joined the Company as Global Head of People  2021/11/05 12:00:00 Business Wire
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving womens health and wellness, principally in breast aesthetics and reconstruction, announced today that Jeffrey Bettinger has been appointed Global Head of People. Mr. Bettinger will join the executive team at Establishment Labs with responsibility for culture, employee experience, and human capital strategy. Mr. Bettinger joins Establishment Labs fr
   Establishment Labs Holdings Inc. (NASDAQ:ESTA) Shares Sold by Kennedy Capital Management Inc.  2021/10/30 12:40:42 Transcript Daily
Kennedy Capital Management Inc. lessened its holdings in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 1.6% in the second quarter, Holdings Channel.com reports. The firm owned 42,775 shares of the companys stock after selling 680 shares during the period. Kennedy Capital Management Inc.s holdings in Establishment Labs were worth $3,736,000 as of its most []
   Establishment Labs Holdings Inc.: Establishment Labs Announces Events for Pink October and Breast Cancer Awareness Month  2021/09/30 20:34:00 FinanzNachrichten
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women''s health and wellness, principally in breast aesthetics and reconstruction, today
   Establishment Labs Announces Events for Pink October and Breast Cancer Awareness Month  2021/09/30 20:30:00 Business Wire
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving womens health and wellness, principally in breast aesthetics and reconstruction, today announced the events and activities planned for the month of October in support of Pink October and Breast Cancer Awareness Month. One in eight women will experience breast cancer in her lifetime. While survival rates have improved, the disease can still have a
   2021 Breast Implants Market Report- Current Demands with Top Companies: GC Aesthetics, Establishment Labs  2021/09/14 11:47:49 OpenPR
The research report of the Breast Implants Market provides a comprehensive overview of the market, size, and share. In addition, Breast Implants Market provides the closest approximations of the revenue of the market and sub-segments across the different regions. The
   Renee Gaeta leaves Establishment Labs to join Eko as CFO  2021/08/02 12:54:36 Seeking Alpha
   Establishment Labs EPS beats by $0.05, beats on revenue  2021/07/29 12:16:27 Seeking Alpha
   Global Breast Tissue Expander Market 2021 Future Set to Massive Growth with High CAGR value | Market Players: Allergan, PMT Corporation, Sientra, Mentor Worldwide, Specialty Surgical Products, GC Aesthetics, HansBiomed, Establishment Labs  2021/07/23 19:31:19 Jumbo News
The report on Global Breast Tissue Expander Market has been provided by researchers for a detailed understanding of market performance over an estimated period of time set from 2021 to 2026. However, this report has introduced a brief overview to provide the reader with better information on this report. This brief description contains a basic []
   Establishment Labs Releases 2020 Corporate Social Responsibility Annual Review  2021/07/20 20:05:00 Business Wire
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on womens health, initially in the breast aesthetics and reconstruction market, today announced publication of its 2020 Corporate Social Responsibility annual review to coincide with the third anniversary of the companys public listing on NASDAQ. As a publicly traded company, we are already subject to the highest standards of governance and compliance, but we are taki
   Establishment Labs adds Ann Custin and Bryan Slotkin to board of directors  2021/07/15 13:22:33 Seeking Alpha

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 エスタブリッシュメント・ラボズ・ホ―ルディングス ESTA Establishment Labs Holdings Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)